{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:20:49Z","timestamp":1773926449001,"version":"3.50.1"},"reference-count":21,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"vor","delay-in-days":815,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>CDC73 mutations frequently underlie the hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism (FIHP), and parathyroid carcinoma. It has also been suggested that CDC73 deletion analysis should be performed in those patients without CDC73 mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>To investigate for CDC73 deletion in a family with FIHP previously reported not to have CDC73 mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods:<\/jats:title>\n                  <jats:p>Eleven members (six affected with primary hyperparathyroidism and five unaffected) were ascertained from the family, and multiplex ligation-dependent probe amplification was performed to detect CDC73 deletion using leukocyte DNA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>A previously unreported deletion of CDC73 involving exons 1\u201310 was detected in five affected members and two unaffected members who were 26 and 39 years of age. Two affected members had parathyroid carcinomas at the ages of 18 and 32 years, and they had Ki-67 proliferation indices of 5 and 14.5% and did not express parafibromin, encoded by CDC73. Primary hyperparathyroidism in the other affected members was due to adenomas and atypical adenomas, and none had jaw tumors. Two affected members had thoracic aortic aneurysms, which in one member occurred with parathyroid carcinoma and renal cysts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>A previously unreported intragenic deletion of exons 1 to 10 of CDC73 was detected in a three-generation family with FIHP, due to adenomas, atypical adenomas, and parathyroid carcinomas. In addition, two affected males had thoracic aortic aneurysms, which may represent another associated clinical feature of this disorder.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-1481","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T17:56:47Z","timestamp":1400003807000},"page":"3044-3048","source":"Crossref","is-referenced-by-count":43,"title":["CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma"],"prefix":"10.1210","volume":"99","author":[{"given":"Eeva","family":"Korpi-Hy\u00f6v\u00e4lti","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sein\u00e4joki Central Hospital (E.K.-H.), 60320 Sein\u00e4joki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Treena","family":"Cranston","sequence":"first","affiliation":[{"name":"Oxford Medical Genetics Laboratory, Churchill Hospital (T.C.), FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeva","family":"Ryh\u00e4nen","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine (E.R., T.S., C.S-J.), FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Arola","sequence":"first","affiliation":[{"name":"Department of Pathology (J.A.), FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"first","affiliation":[{"name":"Department of Medical Genetics (K.A), Helsinki University Central Hospital, FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Sane","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine (E.R., T.S., C.S-J.), FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh V.","family":"Thakker","sequence":"first","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford (R.V.T.), Oxford OX1 2JD, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Schalin-J\u00e4ntti","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine (E.R., T.S., C.S-J.), FI-00290 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613052316400_B1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"2020071613052316400_B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s002689900188","article-title":"Familial hyperparathyroidism without multiple endocrine neoplasia","volume":"21","author":"Huang","year":"1997","journal-title":"World J Surg"},{"key":"2020071613052316400_B3","first-page":"2114","article-title":"Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21\u2013q32 in a subset of families","volume":"83","author":"Teh","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613052316400_B4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroid syndrromes and parathyroid tumors","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin Endocrinol"},{"key":"2020071613052316400_B5","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","article-title":"Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)","volume":"41","author":"Villablanca","year":"2004","journal-title":"J Med Genet"},{"key":"2020071613052316400_B6","first-page":"944","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21\u2013q31","volume":"56","author":"Szab\u00f3","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2020071613052316400_B7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/340093","article-title":"Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2","volume":"70","author":"Hobbs","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2020071613052316400_B8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"2020071613052316400_B9","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2020071613052316400_B10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"2020071613052316400_B11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613052316400_B12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"key":"2020071613052316400_B13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","article-title":"Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism","volume":"76","author":"Domingues","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613052316400_B14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","article-title":"Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family","volume":"50","author":"Casc\u00f3n","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"2020071613052316400_B15","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613052316400_B16","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613052316400_B17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"key":"2020071613052316400_B18","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","article-title":"Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance","volume":"91","author":"Guarnieri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613052316400_B19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"2020071613052316400_B20","doi-asserted-by":"crossref","first-page":"324964","DOI":"10.1155\/2010\/324964","article-title":"Parafibromin as a diagnostic instrument for parathyroid carcinoma-lone ranger or part of the posse?","volume":"2010","author":"Juhlin","year":"2010","journal-title":"Int J Endocrinol"},{"key":"2020071613052316400_B21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002689900567","article-title":"Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease","volume":"23","author":"Farnebo","year":"1999","journal-title":"World J Surg"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/9\/3044\/20288630\/jcem3044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/9\/3044\/20288630\/jcem3044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:57:03Z","timestamp":1594940223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/9\/3044\/2537740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-1481","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}